Date:April 23, 2026

The inaugural AORTIC–Bio Usawa Microgrant Program brings together a cohort of early- and mid-career researchers, each addressing critical gaps in cancer care systems.
Today, we are happy to present Norman Carl Swart.
His research investigates factors influencing adherence to endocrine therapy among women with breast cancer in Botswana — a key determinant of treatment outcomes.
Understanding and addressing adherence challenges is essential to ensuring that available therapies deliver their full impact.
The AORTIC–Bio Usawa Microgrant Program was launched to support African researchers addressing serious gaps in cancer care systems. Out of more than 150…
April 2026The AORTIC—Bio Usawa Microgrant Program is supporting a cohort of five early-career researchers advancing practical solutions in cancer care. The group …
April 2026Over the next few days, we will spotlight the inaugural cohort of the AORTIC—Bio Usawa Microgrant Program for early- and mid-career cancer researchers. …
April 2026